Cui Zhai
Impact in
-
- Pulmonary Hypertension Research and Treatments
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Ubiquitin and proteasome pathways 4
- Circular RNAs in diseases 3
- FOXO transcription factor regulation 3
- Signaling Pathways in Disease 2
-
- Pulmonary Hypertension Research and Treatments 10
- Co-authors
- Manxiang Li (26 shared papers)Xin Yan (22 shared papers)Wenhua Shi (20 shared papers)Qingting Wang (19 shared papers)Yanting Zhu (17 shared papers)Limin Chai (14 shared papers)Jian Wang (11 shared papers)Qianqian Zhang (16 shared papers)
- Journals
- European Journal of Pharmacology (3 papers)Life Sciences (3 papers)Scientific Reports (2 papers)Journal of Cellular Physiology (2 papers)BMC Pulmonary Medicine (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Cui Zhai
29 papers receiving 577 citations
Peers
Comparison fields: 5 of 82
- Pulmonary and Respiratory Medicine 196
- Cancer Research 85
- Microbiology 4
- Molecular Biology 276
- Molecular Medicine 19
Countries citing papers authored by Cui Zhai
This map shows the geographic impact of Cui Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui Zhai more than expected).
Fields of papers citing papers by Cui Zhai
This network shows the impact of papers produced by Cui Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui Zhai. The network helps show where Cui Zhai may publish in the future.
Co-authors
The 25 scholars most cited alongside Cui Zhai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 94 | |
| 2 | 2018 | 58 | |
| 3 | 2018 | 42 | |
| 4 | 2018 | 36 | |
| 5 | 2018 | 33 | |
| 6 | 2017 | 29 | |
| 7 | 2018 | 28 | |
| 8 | 2018 | 26 | |
| 9 | 2018 | 23 | |
| 10 | 2019 | 22 | |
| 11 | 2021 | 22 | |
| 12 | 2019 | 20 | |
| 13 | 2015 | 18 | |
| 14 | 2017 | 17 | |
| 15 | 2019 | 16 | |
| 16 | 2019 | 14 | |
| 17 | 2017 | 13 | |
| 18 | 2020 | 12 | |
| 19 | 2020 | 11 | |
| 20 | 2017 | 10 |
About Cui Zhai
Cui Zhai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Epidemiology, having authored 31 papers that have together received 583 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (10 papers), Cancer-related molecular mechanisms research (7 papers), Ubiquitin and proteasome pathways (4 papers), Autophagy in Disease and Therapy (4 papers), Circular RNAs in diseases (3 papers), FOXO transcription factor regulation (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Signaling Pathways in Disease (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (196 citations), Cancer Research (85 citations), Microbiology (4 citations), Molecular Biology (276 citations) and Molecular Medicine (19 citations). Cui Zhai has collaborated with scholars based in China and United States. Frequent co-authors include Manxiang Li, Xin Yan, Wenhua Shi, Qingting Wang, Yanting Zhu, Limin Chai, Jian Wang, Qianqian Zhang, Shaojun Li and Wei Feng. Their work appears in journals such as European Journal of Pharmacology, Life Sciences, Scientific Reports, Journal of Cellular Physiology and BMC Pulmonary Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.